Physician Assistant, Medical · San Luis Obispo, CA
NPI
1942646393
Since 2013
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
35 Casa St Ste 370
San Luis Obispo, CA, 93405
Phone (805) 541-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$285K
70,235 services
Medicare patients, 2024
498
Average age 77
Drug cost, 2024
$521K
2,639 prescriptions
Company payments, 2025
$1,905
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shermin Y Rutherford was code J3145 (injection, testosterone undecanoate, 1 mg), 61,501 times for 33 patients. In total Shermin Y Rutherford billed 70,235 services in 32 codes, and Medicare paid $285K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-26.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3145 Injection, testosterone undecanoate, 1 mg | Office | 61,501 | 33 | $1.48 | $91K |
| J0897 Injection, denosumab, 1 mg | Office | 5,100 | 12 | $20.44 | $104K |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,000 | 18 | $2.22 | $4,438 |
| 81003 Clinical Chemistry | Office | 318 | 263 | $2.20 | $700 |
| 99214 Office E&M - Established | Office | 248 | 220 | $80.49 | $20K |
| 64566 Musculoskeletal | Office | 149 | 38 | $78.67 | $12K |
| 96372 Injection Administration | Office | 147 | 49 | $10.19 | $1,497 |
| 99213 Office E&M - Established | Office | 124 | 116 | $60.72 | $7,530 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 87 | 16 | $134.12 | $12K |
| 51798 Ultrasound - Nonspecific | Office | 76 | 71 | $9.54 | $725 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 52 | 52 | $8.85 | $460 |
| 51797 Other Organ Systems | Office | 47 | 46 | $140.06 | $6,583 |
| 51784 Neurologic | Office | 47 | 46 | $22.87 | $1,075 |
| 51741 Test - Miscellaneous | Office | 47 | 46 | $5.12 | $241 |
| 51720 Chemotherapy Administration | Office | 39 | 17 | $61.70 | $2,406 |
By year: 2022 $29K for 5,341 services; 2023 $225K for 48,589 services; 2024 $285K for 70,235 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 318 | 263 | $2.20 | $700 |
Medicare prescription drug claims, 2024
In 2024, the drug Shermin Y Rutherford prescribed most often to Medicare patients was Tamsulosin Hcl, with 447 prescriptions and refills. In total Shermin Y Rutherford wrote 2,639 Medicare prescriptions that cost $521K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 447 | 1,221 | 160 | $9,810 |
| Myrbetriq Mirabegron | 250 | 502 | 85 | $225K |
| Finasteride Generic | 192 | 556 | 71 | $3,387 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 170 | 263 | 121 | $4,455 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 157 | 163 | 128 | $570 |
| Gemtesa Vibegron | 146 | 358 | 60 | $168K |
| Methenamine Hippurate Generic | 133 | 359 | 59 | $16K |
| Estradiol Generic | 127 | 388 | 61 | $9,210 |
| Cephalexin Generic | 86 | 140 | 59 | $698 |
| Ciprofloxacin Hcl Generic | 86 | 86 | 69 | $444 |
| Silodosin Generic | 71 | 169 | 26 | $6,741 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 71 | 153 | 29 | $1,982 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 54 | 54 | 41 | $660 |
| Cefdinir Generic | 53 | 53 | 48 | $757 |
| Levofloxacin Generic | 50 | 50 | 44 | $209 |
Brand drugs: 452 claims; generic drugs: 2,175 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shermin Y Rutherford $1,905 ($1,905 in general payments such as food, travel and fees) from 17 companies. The largest payer was Janssen Biotech, Inc. with $390.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 9 | $390 |
| Abbvie Inc. ABBV | 13 | $279 |
| Dendreon Pharmaceuticals LLC | 7 | $242 |
| Pfizer Inc. PFE | 11 | $225 |
| Procept Biorobotics Corporation PRCT | 1 | $118 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $112 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $106 |
| Astellas Pharma US Inc 4503.T | 4 | $96.2 |
| Progenics Pharmaceuticals, Inc. | 3 | $73.92 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $60.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.